Gabelli Funds LLC lessened its position in shares of H.B. Fuller (NYSE:FUL - Free Report) by 2.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 299,800 shares of the specialty chemicals company's stock after selling 8,900 shares during the quarter. Gabelli Funds LLC owned approximately 0.55% of H.B. Fuller worth $20,231,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in FUL. Jones Financial Companies Lllp increased its stake in shares of H.B. Fuller by 128.8% in the 4th quarter. Jones Financial Companies Lllp now owns 899 shares of the specialty chemicals company's stock valued at $61,000 after purchasing an additional 506 shares in the last quarter. Sterling Capital Management LLC raised its stake in shares of H.B. Fuller by 731.1% during the 4th quarter. Sterling Capital Management LLC now owns 1,255 shares of the specialty chemicals company's stock worth $85,000 after buying an additional 1,104 shares during the period. Quantbot Technologies LP purchased a new position in shares of H.B. Fuller during the 4th quarter valued at approximately $266,000. New Age Alpha Advisors LLC purchased a new stake in H.B. Fuller in the 4th quarter worth $465,000. Finally, KLP Kapitalforvaltning AS acquired a new position in H.B. Fuller during the fourth quarter worth $783,000. Hedge funds and other institutional investors own 95.93% of the company's stock.
H.B. Fuller Trading Down 1.8 %
Shares of H.B. Fuller stock traded down $0.98 during mid-day trading on Monday, hitting $52.73. The stock had a trading volume of 43,109 shares, compared to its average volume of 373,637. The firm has a market cap of $2.86 billion, a P/E ratio of 22.83, a price-to-earnings-growth ratio of 1.13 and a beta of 1.27. The company has a quick ratio of 1.16, a current ratio of 1.81 and a debt-to-equity ratio of 1.10. The firm has a 50-day moving average of $55.33 and a two-hundred day moving average of $65.46. H.B. Fuller has a 12-month low of $47.56 and a 12-month high of $87.67.
H.B. Fuller (NYSE:FUL - Get Free Report) last announced its quarterly earnings results on Wednesday, March 26th. The specialty chemicals company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.49 by $0.05. The business had revenue of $788.66 million for the quarter, compared to analyst estimates of $769.55 million. H.B. Fuller had a return on equity of 12.01% and a net margin of 3.65%. The company's quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.67 EPS. Sell-side analysts forecast that H.B. Fuller will post 4.07 earnings per share for the current year.
H.B. Fuller Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, May 13th. Investors of record on Tuesday, April 29th will be issued a $0.235 dividend. This represents a $0.94 annualized dividend and a yield of 1.78%. The ex-dividend date is Tuesday, April 29th. This is an increase from H.B. Fuller's previous quarterly dividend of $0.22. H.B. Fuller's dividend payout ratio (DPR) is 47.00%.
Insider Buying and Selling at H.B. Fuller
In other H.B. Fuller news, CEO Celeste Beeks Mastin purchased 3,500 shares of H.B. Fuller stock in a transaction dated Tuesday, April 1st. The shares were acquired at an average price of $56.66 per share, with a total value of $198,310.00. Following the completion of the transaction, the chief executive officer now owns 3,500 shares of the company's stock, valued at $198,310. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.99% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
FUL has been the subject of several research analyst reports. Vertical Research downgraded shares of H.B. Fuller from a "buy" rating to a "hold" rating in a research report on Monday, January 6th. Seaport Res Ptn cut H.B. Fuller from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft decreased their price objective on H.B. Fuller from $75.00 to $72.00 and set a "buy" rating on the stock in a report on Wednesday, January 22nd. Robert W. Baird upgraded shares of H.B. Fuller from a "neutral" rating to an "outperform" rating and set a $60.00 target price for the company in a research report on Thursday. Finally, Citigroup dropped their price objective on shares of H.B. Fuller from $78.00 to $68.00 and set a "neutral" rating for the company in a research note on Friday, January 3rd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, two have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $62.50.
Read Our Latest Stock Analysis on FUL
H.B. Fuller Profile
(
Free Report)
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
See Also

Before you consider H.B. Fuller, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and H.B. Fuller wasn't on the list.
While H.B. Fuller currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.